Leslie R. Harrold, MD, MPH, associate professor of orthopedics & physical rehabilitation, explains the difference between treatments for acute and chronic gout.
An editorial references the opening of UMass Medical School’s Baystate Health regional clinical campus in Springfield, known as UMMS-Baystate Health, as a sign of economic development.
Todd Brisky is running the 2018 Boston Marathon to raise money for the ALS Cellucci Fund at UMass Medical School. A friend of Mr. Brisky's was diagnosed with ALS last year.
Jerry H. Gurwitz, MD, the Dr. John Meyers Professor of Primary Care Medicine and professor of medicine and family medicine & community health, offers advice for maintaining health as we age.
Warren J. Ferguson, MD, professor of medicine & community health, talks about treating patients with opioid addiction in a correctional setting.
John Landers, PhD, professor of neurology, led a team of more than 250 scientists who found that variations in the KIF5A gene cause both sporadic and familial ALS.
Guangping Gao, PhD, the Penelope Booth Rockwell Professor in Biomedical Research, professor of microbiology & physiological systems, and director of the Horae Gene Therapy Center, discusses the latest advances in his search for a cure for Canavan disease, which will be supported by the Li Weibo Institute for Rare Diseases Research, founded by a $10 million endowment gift from the Li Weibo Charitable Foundation in China.
On Match Day, the School of Medicine Class of 2018 learned where they will begin their careers as doctors. Chancellor Michael F. Collins, and fourth year students Michele Sainvil, Evangelia Murray, and Jonathan Quang were interviewed.
Fortress Biotech and Aevitas Therapeutics, one of its 11 subsidiaries, have entered into a sponsored research agreement with Guangping Gao, PhD, the Penelope Booth Rockwell Professor in Biomedical Research, professor of microbiology & physiological systems, and director of the Horae Gene Therapy Center, to evaluate construct optimization in the development of gene therapies based on adeno-associated virus technology.
A study by Job Dekker, PhD, Howard Hughes Medical Institute Investigator, the Joseph J. Byrne Chair in Biomedical Research, professor of biochemistry & molecular pharmacology and co-director of the Program in Systems Biology, shows how cells quickly pack long chromosomes into compact, organized bundles, a key step before cells divide.
Five-year-old Aliya Sawyer, who has vitiligo, will speak at World Vitiligo Day Conference at UMMS on June 25.
Physician-scientist Jennifer Wang, MD, associate professor of medicine, talks to the media about her research for potential drug therapies that could more effectively treat influenza, reduce its symptoms, boost the immune system and get around the problem of drug resistance.
In an op-ed, David Clive, MD, professor of medicine, draws on his experiences as a physician and teaching medical students how to practice compassionate end-of-life care to advocate for legalizing the option for physician-assisted death.
Jim Glasheen, PhD, executive vice chancellor of innovation and business development, sits down with the Telegram & Gazette to discuss his arrival at UMMS and his vision for the Office of Innovation and Business Development at the medical school.
UMass Medical School is referenced in a story about treating stroke using clot dissolving drugs.
Mark Neavyn, MD, assistant professor of emergency medicine, comments for a story on opioid-related deaths in Massachusetts.
Darwin’s Dogs, a project by Elinor Karlsson, PhD, assistant professor of molecular medicine, collects canine DNA with the hope of using the information as a basis for studies of obsessive compulsive disorder and behavioral conditions.
Jerry Gurwitz, MD, the Dr. John Meyers Professor of Primary Care Medicine and professor of medicine and family medicine & community health, comments on the dramatic decrease in the use of antipsychotic drugs in nursing homes.